What is the role of capecitabine (Xeloda) in the treatment of colon cancer?

Updated: Apr 15, 2020
  • Author: Tomislav Dragovich, MD, PhD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print

The randomized XACT study demonstrated the noninferiority of capecitabine (Xeloda) compared with fluorouracil/leucovorin as adjuvant therapy for patients with stage III colon cancer. A large trial comparing capecitabine plus oxaliplatin (XELOX) versus FOLFOX has completed accrual, but survival data have not yet been reported.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!